LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Recalls and defects › 9 Jan 2024
Medicines recall

EL(25)A/01

Issued on 9 Jan 2024 · source: MHRA — Medicines and Healthcare products Regulatory Agency
Class 4 recall
Check the batch number on the pack. The medicine remains licensed; other batches are not affected.
Class 4 recall · DMRC 33946703 · licence holder: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets

What this means

The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.

Class 4 recall · DMRC 33946703

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.